Brokerages forecast that Acadia Healthcare Company Inc (NASDAQ:ACHC) will announce $0.70 earnings per share for the current fiscal quarter, Zacks reports. Seven analysts have issued estimates for Acadia Healthcare’s earnings. The highest EPS estimate is $0.77 and the lowest is $0.68. Acadia Healthcare reported earnings per share of $0.66 in the same quarter last year, which would suggest a positive year over year growth rate of 6.1%. The company is scheduled to announce its next earnings results on Thursday, July 26th.
According to Zacks, analysts expect that Acadia Healthcare will report full year earnings of $2.58 per share for the current year, with EPS estimates ranging from $2.44 to $2.62. For the next year, analysts forecast that the company will report earnings of $2.82 per share, with EPS estimates ranging from $2.61 to $3.00. Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that follow Acadia Healthcare.
Get Acadia Healthcare alerts:Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, May 1st. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.04. Acadia Healthcare had a net margin of 7.34% and a return on equity of 7.99%. The firm had revenue of $742.20 million during the quarter, compared to analyst estimates of $727.64 million. During the same quarter last year, the business earned $0.46 EPS. The company’s revenue was up 9.3% compared to the same quarter last year.
Several research analysts have issued reports on the stock. Zacks Investment Research upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Monday, February 12th. ValuEngine lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Saturday, April 7th. BMO Capital Markets restated an “outperform” rating and set a $45.00 price target (up previously from $40.00) on shares of Acadia Healthcare in a report on Friday, February 23rd. BidaskClub upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, February 22nd. Finally, Robert W. Baird set a $42.00 price target on shares of Acadia Healthcare and gave the stock a “hold” rating in a report on Thursday, February 22nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $44.50.
In related news, Director Reeve B. Waud sold 200,000 shares of Acadia Healthcare stock in a transaction on Tuesday, March 6th. The shares were sold at an average price of $39.02, for a total value of $7,804,000.00. Following the completion of the sale, the director now owns 10,088 shares of the company’s stock, valued at approximately $393,633.76. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Randall P. Goldberg sold 960 shares of Acadia Healthcare stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $38.47, for a total transaction of $36,931.20. Following the completion of the sale, the vice president now directly owns 6,942 shares of the company’s stock, valued at approximately $267,058.74. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 401,360 shares of company stock valued at $15,759,096. Insiders own 11.10% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. grew its position in Acadia Healthcare by 0.9% in the 1st quarter. BlackRock Inc. now owns 10,125,714 shares of the company’s stock valued at $396,726,000 after purchasing an additional 91,981 shares during the period. Aristotle Capital Management LLC grew its position in Acadia Healthcare by 7.4% in the 1st quarter. Aristotle Capital Management LLC now owns 6,638,790 shares of the company’s stock valued at $260,108,000 after purchasing an additional 454,924 shares during the period. Dimensional Fund Advisors LP grew its position in Acadia Healthcare by 41.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,031,525 shares of the company’s stock valued at $157,955,000 after purchasing an additional 1,178,151 shares during the period. P2 Capital Partners LLC grew its position in Acadia Healthcare by 14.5% in the 1st quarter. P2 Capital Partners LLC now owns 3,350,000 shares of the company’s stock valued at $131,253,000 after purchasing an additional 425,000 shares during the period. Finally, Bank of New York Mellon Corp grew its position in Acadia Healthcare by 6.8% in the 4th quarter. Bank of New York Mellon Corp now owns 1,379,499 shares of the company’s stock valued at $45,013,000 after purchasing an additional 87,260 shares during the period.
Acadia Healthcare stock traded down $0.25 during mid-day trading on Friday, hitting $42.01. 736,675 shares of the stock were exchanged, compared to its average volume of 1,160,284. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.29 and a current ratio of 1.29. Acadia Healthcare has a 12 month low of $26.92 and a 12 month high of $54.34. The firm has a market cap of $3.73 billion, a price-to-earnings ratio of 18.27, a PEG ratio of 1.30 and a beta of 0.64.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment